Elekta announced that Providence Health and Services in Renton, Wash., the nation's third largest not-for-profit health system, has ordered multiple Elekta cancer management solutions, including radiation therapy systems and upgrades, oncology information systems and multiyear service contracts for its hospitals, clinics and other health care facilities in Washington, Alaska, California, Montana and Oregon.
In 2012, Providence and Seattle's Swedish Health Services affiliated, bringing together two of the region's largest health care organizations. The Swedish Cancer Institute was a long-time partner with Elekta in the provision of cancer management resources in the northwest.
"Our new partnership with Providence continues a mutually beneficial tradition in which two organizations work together to build value for thousands of individuals in this region who need world-class health care," said Jay Hoey, executive vice president, Elekta North America. "We're jointly creating something that is more than a traditional vendor-customer relationship — it's an alliance of two entities with a common vision to improve patients' lives."
In the agreement, Providence Health and Services will acquire several Versa HD systems, Elekta's most advanced radiation therapy system (linear accelerator), featuring sophisticated beam shaping technology combined with high dose rate delivery. Versa HD is designed to give clinicians the flexibility to deliver conventional therapies to treat a wide range of small and large tumors throughout the body, while also enabling treatment of highly complex cancers that require extreme targeting precision.
In addition, Elekta will provide upgrades to several existing Elekta systems, including the integration of Agility 160-leaf multileaf collimator (MLC) and XVI (5.0) software.
In a significant acquisition of Elekta software, Providence also will begin a system-wide conversion of its existing oncology information system to Mosaiq Oncology Information System.
Installation of the Elekta systems is set to begin immediately, continuing through the end of 2016.
For more information: www.elekta.com
April 29, 2024 
